Statistics

Total Visits

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies79

Select a period of time:

Number of views in the range

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies52

Views

Views
March 202514
April 20254
May 20250
June 20250
July 202527
August 20250
September 20257
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States14
Brazil14
United Kingdom2
Hong Kong2
Ecuador2
Germany1
Spain1
Morocco1
South Africa1
 

Top cities views

Views
Dallas5
Rio de Janeiro2
Hong Kong2
Ambato1
Baltimore1
Cape Town1
Council Bluffs1
Dayton1
Diadema1
Indaiatuba1